[Therapeutic effects of a new oxazin derivative on diabetes insipidus].
D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003919:Diabetes Insipidus / Q000150:complications*; D006801:Humans; D009765:Obesity / Q000150:complications*
D000697:Central Nervous System Stimulants
ANALEPTICS/therapeutic use; DIABETES INSIPIDUS/complications; OBESITY/complications
Beeinflussung des Diabetes insipidus durch einen neuen Oxazinabkömmling.